Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Collapsed Microbiome Biotech Sells Off Assets

Microbiome illustration

A developer of therapies addressing the body’s microbe communities is selling off key assets to another biotechnology company, after problems developed with its lead program. . . . → Read More: Collapsed Microbiome Biotech Sells Off Assets

Vaccine Shown to Protect Against Multiple Hospital Pathogens

MRSA bacteria

Research with lab mice shows an experimental vaccine stimulates the body’s basic immune system to protect against a range of pathogens associated with hospital infections. . . . → Read More: Vaccine Shown to Protect Against Multiple Hospital Pathogens

Cardiac Tech Start-Up Partners with Mayo Clinic

Digital pulse time-series image

A new company developing digital cardiac diagnostics is collaborating with the Mayo Clinic on early detection of coronary artery disease, a key trigger of heart attacks. . . . → Read More: Cardiac Tech Start-Up Partners with Mayo Clinic

University Start-Up Developing Inhaled Gene Therapies

Inspecting lung X-rays

A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies

Venture Firm, Cancer Center Start Antibody Biotech Company

Antibody illustration

A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company

Company Gains Ultrasound-Linked Drug Capsule Technology

DNA bubbles illustration

A company developing a drug delivery process with treatments activated by ultrasound received an option to license a key technology from its founders’ university labs. . . . → Read More: Company Gains Ultrasound-Linked Drug Capsule Technology

Companies to Assess Ovarian Health Biotech Drug

Women silhouettes

A women’s health biotechnology company is partnering with a Brazilian drug maker to evaluate a precision target and treatment for ovarian health disorders. . . . → Read More: Companies to Assess Ovarian Health Biotech Drug

Bio-Friendly Plant Nutrient Delivery Patent Awarded

Seedlings in soil

A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent. . . . → Read More: Bio-Friendly Plant Nutrient Delivery Patent Awarded

Patent Issued for Synthetic Peptide Chain Techniques

U.S. Patent and Trademark Office

A new U.S. patent, licensed to a start-up biotechnology company, describes processes for linking together chains of synthetic peptides into therapeutic proteins. . . . → Read More: Patent Issued for Synthetic Peptide Chain Techniques

Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Editing DNA

A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal